ES8702416A1 - Un procedimiento para la preparacion de dihidro piridin lactonas - Google Patents

Un procedimiento para la preparacion de dihidro piridin lactonas

Info

Publication number
ES8702416A1
ES8702416A1 ES551544A ES551544A ES8702416A1 ES 8702416 A1 ES8702416 A1 ES 8702416A1 ES 551544 A ES551544 A ES 551544A ES 551544 A ES551544 A ES 551544A ES 8702416 A1 ES8702416 A1 ES 8702416A1
Authority
ES
Spain
Prior art keywords
alkyl
atoms
chain
optionally
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551544A
Other languages
English (en)
Other versions
ES551544A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES551544A0 publication Critical patent/ES551544A0/es
Publication of ES8702416A1 publication Critical patent/ES8702416A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Endoscopes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DIHIDROPIRIDINLACTONAS. CONSISTENTE EN: HACER REACCIONAR ILIDENCOMPUESTOS DE FORMULA GENERAL (X) CON ENAMINAS DE FORMULA (VIII), EN PROPORCION MOLAR, EN AGUA O DISOLVENTES ORGANICOS INERTES, PREFERENTEMENTE EN ALCLHOLES COMO EL METANOL, ETANOL Y OTROS, Y A TEMPERATURAS ENTRE 20 Y 150JC, PARA OBTENER COMPUESTOS DE FORMULA (I). SIENDO: R F HALOGENO, ALQUILO CON 1 A 10 C, ALQUILTIO CON 1 A 10C, CIANO, MONO O POLIFLUORALQUILO CON UNO A SEIS CARBONOS, Y OTROS; R1 F H, HALOGENO, O ALQUILO O ALCOXI CON 1 A 10C; R2 F UN RESTO HIDROCARBONADO CON 1 A 20 ATOMOS DE CARBONO, DE CADENA LINEAL, RAMIFICADA O CICLICA, SATURADO O INSATURADO; R3 F H, NH2, CHO, CN O UN RESTO HIDROCARBONADO DE 1 A 6 C; Y R4 UN RESTO ALQUILO O UN RESTO ALQUENILO. UTILIZABLES COMO FARMACOS QUE DISMINUYEN EL AZUCAR EN SANGRE, EN EL TRATAMIENTO DE LA DIABETES.
ES551544A 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas Expired ES8702416A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843410645 DE3410645A1 (de) 1984-03-23 1984-03-23 L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES551544A0 ES551544A0 (es) 1987-01-01
ES8702416A1 true ES8702416A1 (es) 1987-01-01

Family

ID=6231357

Family Applications (9)

Application Number Title Priority Date Filing Date
ES541309A Expired ES8607309A1 (es) 1984-03-23 1985-03-15 Dihidropiridinlactonas
ES551543A Expired ES8702415A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551544A Expired ES8702416A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551541A Expired ES8702413A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551548A Expired ES8702418A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551542A Expired ES8702414A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551546A Expired ES8704173A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551547A Expired ES8704174A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551545A Expired ES8702417A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES541309A Expired ES8607309A1 (es) 1984-03-23 1985-03-15 Dihidropiridinlactonas
ES551543A Expired ES8702415A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas

Family Applications After (6)

Application Number Title Priority Date Filing Date
ES551541A Expired ES8702413A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551548A Expired ES8702418A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551542A Expired ES8702414A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551546A Expired ES8704173A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551547A Expired ES8704174A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas
ES551545A Expired ES8702417A1 (es) 1984-03-23 1986-01-31 Un procedimiento para la preparacion de dihidro piridin lactonas

Country Status (24)

Country Link
US (1) US5026714A (es)
EP (1) EP0158138B1 (es)
JP (1) JPS60209584A (es)
KR (1) KR850006439A (es)
AT (1) ATE37880T1 (es)
AU (1) AU569783B2 (es)
CA (1) CA1249270A (es)
CS (1) CS250681B2 (es)
DD (1) DD234424A5 (es)
DE (2) DE3410645A1 (es)
DK (1) DK158517C (es)
EG (1) EG16785A (es)
ES (9) ES8607309A1 (es)
FI (1) FI83651C (es)
GR (1) GR850719B (es)
HU (1) HU191167B (es)
IL (1) IL74659A (es)
NO (1) NO161259C (es)
NZ (1) NZ211512A (es)
PH (3) PH23826A (es)
PL (1) PL143884B1 (es)
PT (1) PT80146B (es)
SU (1) SU1319785A3 (es)
ZA (1) ZA852172B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3521761A1 (de) * 1985-06-19 1987-01-02 Bayer Ag Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US5162338A (en) * 1986-01-11 1992-11-10 Bayer Aktiengesellschaft Circulation active 4-aminoaryldihydropryidine lactones
DE3600596A1 (de) * 1986-01-11 1987-07-16 Bayer Ag 4-aminoaryldihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3629545A1 (de) * 1986-08-30 1988-03-10 Bayer Ag Dihydropyridinverbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE3706204A1 (de) * 1987-02-26 1988-09-08 Bayer Ag Benzylaminoaryl-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB8716971D0 (en) * 1987-07-17 1987-08-26 Pfizer Ltd Therapeutic agents
DE4430092A1 (de) * 1994-08-25 1996-02-29 Bayer Ag 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TW200519091A (en) * 2003-09-10 2005-06-16 Synta Pharmaceuticals Corp Dihydropyridine compounds for treating or preventing metabolic disorders
WO2021253180A1 (en) * 2020-06-15 2021-12-23 Novartis Ag Methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-4, 5, 6, 7-tetrahydro-1h-cyclopenta [b] pyridine-3-carboxylate and methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-1, 4, 5, 7-tetrahydrofuro [3, 4-b] pyridine-3-carboxylate as cav1.2 activators
KR20230022979A (ko) 2020-06-16 2023-02-16 노파르티스 아게 CAV1.2 활성제로서의 메틸 2-메틸-5-옥소-1,4,5,7-테트라하이드로푸로[3,4-b]피리딘-3-카르복실레이트 화합물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
US4253248A (en) 1979-04-16 1981-03-03 Cornish Judson E Teaching machine apparatus
DE3206671A1 (de) * 1982-02-25 1983-09-01 Bayer Ag, 5090 Leverkusen Dihydropyridine mit positiv inotroper wirkung, neue verbindungen, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3130041A1 (de) * 1981-07-30 1983-02-17 Bayer Ag, 5090 Leverkusen Dihydropyridine mit positiv inotroper wirkung, neue verbindungen, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
DE3209274A1 (de) * 1982-03-13 1983-09-15 Bayer Ag, 5090 Leverkusen Pyridincarbonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3209276A1 (de) * 1982-03-13 1983-09-15 Bayer Ag, 5090 Leverkusen Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung
EP0111455A3 (de) * 1982-12-10 1984-07-25 Ciba-Geigy Ag Ungesättigte Lactone
DE3521761A1 (de) * 1985-06-19 1987-01-02 Bayer Ag Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3601226A1 (de) * 1986-01-17 1987-07-23 Bayer Ag Dihydropyridinlactole, verfahren zur herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
FI83651B (fi) 1991-04-30
ES551544A0 (es) 1987-01-01
ES8702417A1 (es) 1986-12-16
PH23455A (en) 1989-08-07
IL74659A0 (en) 1985-06-30
DK158517B (da) 1990-05-28
EP0158138A1 (de) 1985-10-16
ES551542A0 (es) 1986-12-16
ES541309A0 (es) 1986-06-16
SU1319785A3 (ru) 1987-06-23
ES8702413A1 (es) 1987-01-01
EG16785A (en) 1990-10-30
IL74659A (en) 1988-11-30
DE3565541D1 (en) 1988-11-17
DE3410645A1 (de) 1985-09-26
ES551547A0 (es) 1987-03-16
DK131685A (da) 1985-09-24
FI83651C (fi) 1991-08-12
FI851143L (fi) 1985-09-24
ES8702414A1 (es) 1986-12-16
NZ211512A (en) 1988-07-28
EP0158138B1 (de) 1988-10-12
GR850719B (es) 1985-07-19
PT80146B (en) 1987-03-23
ES551541A0 (es) 1987-01-01
ZA852172B (en) 1985-12-24
NO161259B (no) 1989-04-17
NO850891L (no) 1985-09-24
JPS60209584A (ja) 1985-10-22
ATE37880T1 (de) 1988-10-15
DD234424A5 (de) 1986-04-02
ES551545A0 (es) 1986-12-16
ES8702415A1 (es) 1986-12-16
PH23826A (en) 1989-11-23
ES8704173A1 (es) 1987-03-16
ES8702418A1 (es) 1986-12-16
ES551543A0 (es) 1986-12-16
DK131685D0 (da) 1985-03-22
FI851143A0 (fi) 1985-03-21
HUT37795A (en) 1986-02-28
ES551546A0 (es) 1987-03-16
ES551548A0 (es) 1986-12-16
ES8704174A1 (es) 1987-03-16
HU191167B (en) 1987-01-28
US5026714A (en) 1991-06-25
CA1249270A (en) 1989-01-24
AU4044985A (en) 1985-09-26
AU569783B2 (en) 1988-02-18
PH24347A (en) 1990-06-13
ES8607309A1 (es) 1986-06-16
CS250681B2 (en) 1987-05-14
PT80146A (en) 1985-04-01
PL252522A1 (en) 1986-04-08
NO161259C (no) 1989-07-26
DK158517C (da) 1990-11-05
PL143884B1 (en) 1988-03-31
KR850006439A (ko) 1985-10-05

Similar Documents

Publication Publication Date Title
ES8702415A1 (es) Un procedimiento para la preparacion de dihidro piridin lactonas
FI860107A (fi) Aminofenolderivat.
GR3002267T3 (en) Dissymmetrical 1,4-dihydropyridine-3,5-dicarboxylic-acid derivatives, preparation processes and therapeutical use
AR005545A1 (es) Un procedimiento para la preparacion de derivados de imidazodiacepina.
ES2074430T3 (es) Compuesto opticamente activo, procedimiento para su fabricacion y composicion de cristal liquido que lo contiene.
MX3412E (es) Procedimiento para la preparacion de 3-fluor benzodiazepinas
EP0238211A3 (en) Dihydropyridines, process for their preparation and their use as medicaments
SU1212093A1 (ru) Состав для обработки призабойной зоны пласта

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603